Alzheimer's Disease

Expanding Evidence-Based Care for Dementia

Jul 13, 2021 at 02:24 pm by Staff

Alzheimer's Association Creates Training, Certification Program The Alzheimer's Association recently launched a new training program with certification exam to advance the de.... Read More

FDA Approves Controversial Alzheimer's Drug

Jul 12, 2021 at 03:30 pm by Staff

On June 7, the Food & Drug Administration approved Aduhelm (aducanumab) to treat Alzheimer's patients, making it the first new drug approval for a disease impacting more t.... Read More

IQuity Awarded Grant to Identify Alzheimer's Earlier

Nov 15, 2018 at 03:11 pm by Staff

Nashville-based data analytics company IQuity recently received a $320,000 grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH). T.... Read More

Alzheimer's Association Sees Increase in Federal Support

May 09, 2018 at 10:45 am by Staff

Patients, Researchers, Caregivers All Score Wins In March, President Donald Trump signed a massive $1.3 trillion omnibus spending bill into law to fund the federal government..... Read More

Vanderbilt Investigational Alzheimer's Drug Scheduled for First Study in Humans

Jan 10, 2017 at 11:16 am by Staff

In late December, Vanderbilt University scientists received the green light from the U.S. Food and Drug Administration (FDA) to proceed to clinical testing in humans for an in.... Read More

Expanding ADNI: Alzheimer's Biomarker Study Embarks on Next Phase

Oct 11, 2016 at 02:55 pm by Staff

The landmark Alzheimer's Disease Neuroimaging Initiative (ADNI) began in October 2004 with a goal of finding more sensitive and accurate methods to detect Alzheimer's disease.... Read More